Byron Donalds bought Abbott Laboratories (NYSE: ABT)
Byron Donalds (R-FL), a U.S. Representative, has disclosed 4 trades in Abbott Laboratories (ABT) since 2025, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Byron Donalds bought $1,001 - $15,000 of Abbott Laboratories (NYSE: ABT) on March 20, 2025. Since that trade, ABT is down -12.67% against the S&P 500 up +30.87%, an outperformance of -43.54%.
Across these filings, Byron Donalds has been a balanced trader of ABT (a buy-to-sell ratio of 1.00). The most recent disclosed ABT transaction shown was dated December 4, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Byron Donalds's ABT trades vs the price
ABT is down -12.67% since Byron Donalds bought on March 20, 2025, versus +30.87% for the S&P 500.
Performance since this trade
All Byron Donalds ABT trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| December 4, 2025 | SELL | $123.99 | -12.90% | — | |
| December 4, 2025 | SELL | $123.99 | -12.90% | — | |
| March 20, 2025 | BUY | $123.67 | -12.67% | -$1K | |
| March 20, 2025 | BUY | $123.67 | -12.67% | -$1K |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Byron Donalds & ABT trading FAQ
Is it legal for Byron Donalds to trade Abbott Laboratories (ABT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Byron Donalds buy ABT?
Byron Donalds disclosed a purchase of $1,001 - $15,000 of Abbott Laboratories (ABT) on March 20, 2025, according to public STOCK Act filings.
How has ABT performed since Byron Donalds's trade?
Since Byron Donalds bought ABT on March 20, 2025, the stock is down -12.67%, versus +30.87% for the S&P 500 over the same period, an outperformance of -43.54%.
How many times has Byron Donalds traded ABT?
Byron Donalds has disclosed 4 ABT trades since 2025 (2 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABT trades?
Quantellect tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.
Byron Donalds's ABT tradesAll congressional filings for Abbott LaboratoriesByron Donalds's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.